Disease/Infection News

RSS

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

Adequate glycemic control during the year after being vaccinated against the SARS-CoV-2 improves the relative immunological response.

15 Mar 2022

Maternal and neonatal outcomes during UK's SARS-CoV-2 Omicron wave

Researchers describe the characteristics of pregnant women hospitalized due to COVID-19.

15 Mar 2022

Serious COVID-19 linked to higher risk of long-term adverse mental health effects

A new study published in The Lancet Public Health journal indicates that serious COVID-19 illness is linked to an increase in the risk of long-term adverse mental health effects.

15 Mar 2022

How capable are children to self-swab for SARS-CoV-2?

Researchers gather data that supports the evidence-based recommendations for children to successfully perform nasal swabs on themselves.

15 Mar 2022

Researchers investigate loss of fitness following COVID-19

Researchers investigate if a decline in exercise capabilities is due to deconditioning during infection or long-term reductions in ability due to COVID-19.

15 Mar 2022

SARS-CoV-2 infection model generated from human tonsil epithelial organoids

Researchers evaluate the feasibility of tonsil epithelial cell-derived organoids as an ex vivo model for studying SARS-CoV-2 infection.

15 Mar 2022

Acacetin shows potency against SARS-CoV-2 spike protein

Researchers use molecular docking to screen phytocompounds and evaluate their binding affinity with SARS-CoV-2.

15 Mar 2022

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Researchers investigate the dynamics of anti-spike IgG levels against the SARS-CoV-2 spike protein in Japanese healthcare workers.

15 Mar 2022

Pathogen works with drug to clear fungal infection, study shows

Pathogens don't always work against drug treatments. Sometimes, they can strengthen them, according to a new University of Maine study.

15 Mar 2022

Researchers receive grant to find answers to taste loss in COVID patients

Up to 80% of individuals who've had COVID-19 report temporary or lasting changes in their sense of taste, and scientists are working to better understand the biological basis of why, including whether our taste buds are a direct virus target.

15 Mar 2022

Omicron emergence in South Africa associated with increased reinfection risk, analysis finds

The Omicron variant of SARS-CoV-2 evades immunity from prior infection, an analysis of routine surveillance data from South Africa indicates.

15 Mar 2022

Recovery of consciousness may take weeks for most COVID patients on respirators

Most patients with severe COVID who are put on ventilators regain consciousness after removal of respiratory support, but recovery may take weeks after the period of mechanical ventilation has ended, according to a new study by investigators at Weill Cornell Medicine, Columbia University Vagelos College of Physicians and Surgeons, Harvard Medical School, NewYork-Presbyterian and Massachusetts General Hospital.

15 Mar 2022

New way to deliver potential HIV vaccine using mRNA technology

Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.

15 Mar 2022

Researchers identify a potential new test for early diagnosis of Lyme disease

For scientists and clinicians alike, one of the Holy Grails for successfully treating and curing Lyme disease is developing tests that identify the disease sooner, show when people are cured of infection, and can diagnose reinfection.

15 Mar 2022

High doses of antibiotic may safely and effectively treat TB meningitis

A Johns Hopkins Children's Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease.

15 Mar 2022